Breaking Barriers in OCD Treatment: A Resistant Case Successfully Treated with an Innovative Exposure and Response Prevention Strategy
DOI:
https://doi.org/10.52783/jns.v14.2798Keywords:
N/AAbstract
It is widely recognized that the most effective approach to treating obsessive-compulsive disorder (OCD) combines medication with cognitive-behavioral therapy (CBT), particularly exposure and response prevention (ERP). This case sheds light on a unique and unconventional way of applying ERP in a patient with treatment-resistant and atypical OCD, ultimately proving more beneficial than medication alone. What made this case unusual was the patient’s deeply ingrained overvalued ideas, superstitions, and strong religious beliefs, which played a significant role in shaping their symptoms. Additionally, the patient tended to misinterpret random events as meaningful, experienced heightened stimulus generalization, and responded best to in vivo exposure, making their treatment journey both challenging and distinct.
Downloads
Metrics
References
Van Ameringen M, Patterson B, Simpson W. DSM-5 obsessive-compulsive and related disorders: Clinical implications of new criteria. Depress Anxiety. 2014;31(6):487–93.
Nolen WA. [World Health Organization places psychiatry high on the agenda, also consequences for the Netherlands]. Ned Tijdschr Geneeskd. 2002;146(7):297–99.
Mataix-Cols D, do Rosario-Campos MC & Leckman JFA Multidimensional model of obsessivecompulsive disorder. Am. J. Psychiatry 162, 228–238 (2005). [PubMed: 15677583]
Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C & Leckman JF Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am. J. Psychiatry 165, 1532–1542 (2008). [PubMed: 18923068]
Karno M The epidemiology of obsessive-compulsive disorder in five US communities. Arch. Gen. Psychiatry 45, 1094 (1988). [PubMed: 3264144]
Baxter AJ, Vos T, Scott KM, Ferrari AJ & Whiteford HA The global burden of anxiety disorders in 2010. Psychol. Med 44, 2363–2374 (2014). [PubMed: 24451993] This systematic review provides the foundation for estimations of the global burden of anxiety and related disorders.
Brander G, Pérez-Vigil A, Larsson H & Mataix-Cols D Systematic review of environmental risk factors for obsessive-compulsive disorder: a proposed roadmap from association to causation. Neurosci. Biobehav. Rev 65, 36–62 (2016). [PubMed: 27013116]
Dykshoorn KL Trauma-related obsessive–compulsive disorder: a review. Health Psychol. Behav. Med 2, 517–528 (2014). [PubMed: 25750799]
Miller ML & Brock RL The effect of trauma on the severity of obsessive-compulsive spectrum symptoms: a meta-analysis. J. Anxiety Disord 47, 29–44 (2017). [PubMed: 28242410]
Fineberg NA, Hollander E, Pallanti S, Walitza S, Grünblatt E, Dell’Osso BM, et al. Clinical advances in obsessive-compulsive disorder: A position statement by the International College of Obsessive-Compulsive Spectrum Disorders. Int Clin Psychopharmacol 2020. https://doi.org/10.1097/YIC.0000000000000314. Publish Ahead of Print
Van Roessel PJ, Grassi G, Aboujaoude EN, Menchón JM, Van Ameringen M, Rodríguez CI. Treatment-resistant OCD: Pharmacotherapies in adults. Comprehensive psychiatry. 2023 Jan 1;120:152352.
Grassi G, Cecchelli C, Mazzocato G, Vignozzi L. Early onset obsessive-compulsive disorder: The biological and clinical phenotype. CNS Spectr 2021;1–7. https:// doi.org/10.1017/S1092852921000122.
Grassi G, Cecchelli C, Vignozzi L, Pacini S. Investigational and experimental drugs to treat obsessive-compulsive disorder. J Exp Pharmacol 2021;12:695–706. https://doi.org/10.2147/JEP.S255375.
de Vries FE, Cath DC, Hoogendoorn AW, van Oppen P, Glas G, Veltman DJ, et al. Tic-related versus tic-free obsessive-compulsive disorder: clinical picture and 2- year natural course. J Clin Psychiatry 2016;77(10):e1240–7. https://doi.org/ 10.4088/JCP.14m09736.
Bandelow B, Sher L, Bunevicius R, Hollander E, Kasper S, Zohar J, et al. Guidelines for the pharmacological treatment of anxiety disorders, obsessive– compulsive disorder and posttraumatic stress disorder in primary care. Int J Psychiatry Clin Pract. 2012;16(2):77–84.
Jenike MA, Rauch SL. Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies. J Clin Psychiatry. 1994;55 Suppl:11–17.
Bloch MH, Landeros-Weisenberger A, Rosario MC, Pittenger C, Leckman JF. Meta-analysis of the symptom structure of obsessive-compulsive disorder. Am J Psychiatry. 2006;163(12):1956-66. doi:10.1176/ajp.2006.163.12.1956. Available at: https://ajp.psychiatryonline.org/doi/full/10.1176/ajp.2006.163.12.1956
March JS, Frances A, Carpenter D, Kahn DA. The Expert Consensus Guideline Series: Treatment of obsessive-compulsive disorder. J Clin Psychiatry. 1997;58 Suppl 4:1-72. Available at: https://www.psychiatrist.com/wp-content/uploads/2021/02/15152_expert_consensus_guideline_series_treatment_of_obsessive-compulsive_disorder.pdf
Stein DJ, Kogan CS, Atmaca M, Fineberg NA, Fontenelle LF, Grant JE, et al. The classification of obsessive-compulsive and related disorders in the ICD-11. J Affect Disord. 2019;259:48-65. doi:10.1016/j.jad.2019.06.016. Available at: https://www.sciencedirect.com/science/article/pii/S0165032718316671
Fineberg NA, Reghunandanan S, Brown A, Pampaloni I. Pharmacotherapy of obsessive-compulsive disorder: Evidence-based treatment and beyond. Aust N Z J Psychiatry. 2019;53(1):24-40. doi:10.1177/0004867418804066. Available at: https://journals.sagepub.com/doi/full/10.1177/0004867418804066
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
